Literature DB >> 19357151

Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients.

I Koutsourelakis1, E Perraki, N T Economou, P Dimitrokalli, E Vagiakis, C Roussos, S Zakynthinos.   

Abstract

Some patients with obstructive sleep apnoea syndrome (OSAS; respiratory distress index (RDI) of >5 events.h(-1)) experience residual excessive daytime subjective sleepiness (Epworth Sleepiness Scale (ESS) score of >10), despite adequate use of continuous positive airway pressure (CPAP) therapy. The aim of the present study was to identify clinical and polysomnographic predictors of this sleepiness. Clinical and polysomnographic variables and ESS score were evaluated in 208 OSAS patients with an ESS score of >10 before (initial assessment) and after > or =6 months of adequate (> or =4 h.day(-1)) CPAP use. Following CPAP treatment, 114 (55%) patients showed an abnormal ESS score (>10; CPAP nonresponders), whereas 94 (45%) showed a normal ESS score (<11; CPAP responders). Of the CPAP responders, none had a history of depression, whereas the converse was true for 38.8% of CPAP nonresponders. In addition, multivariate logistic regression analysis revealed that the independent predictors of residual excessive daytime sleepiness following CPAP therapy were a history of diabetes and heart disease, and a higher ESS score and lower RDI on initial assessment. In conclusion, predictors of residual excessive sleepiness in adequately CPAP-treated OSAS were a history of depression, diabetes and heart disease, and a higher ESS score and lower RDI on initial assessment.

Entities:  

Mesh:

Year:  2009        PMID: 19357151     DOI: 10.1183/09031936.00124708

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  What is the best measure of daytime sleepiness in adults with heart failure?

Authors:  Barbara Riegel; Alexandra L Hanlon; Xuemei Zhang; Desiree Fleck; Steven L Sayers; Lee R Goldberg; William S Weintraub
Journal:  J Am Assoc Nurse Pract       Date:  2012-09-24       Impact factor: 1.165

2.  Comorbidities, Health-Related Quality of Life, and Work Productivity Among People With Obstructive Sleep Apnea With Excessive Sleepiness: Findings From the 2016 US National Health and Wellness Survey.

Authors:  Carl Stepnowsky; Kathleen F Sarmiento; Shay Bujanover; Kathleen F Villa; Vicky W Li; Natalia M Flores
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

3.  Adaptive pressure support servoventilation: a novel treatment for residual sleepiness associated with central sleep apnea events.

Authors:  Mei Su; Xilong Zhang; Mao Huang; Ning Ding
Journal:  Sleep Breath       Date:  2010-09-23       Impact factor: 2.816

4.  Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.

Authors:  Paula K Schweitzer; Russell Rosenberg; Gary K Zammit; Mark Gotfried; Dan Chen; Lawrence P Carter; Hao Wang; Yuan Lu; Jed Black; Atul Malhotra; Kingman P Strohl
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

5.  Comorbidity modulates non invasive ventilation-induced changes in breath print of obstructive sleep apnea syndrome patients.

Authors:  Raffaele Antonelli Incalzi; Giorgio Pennazza; Simone Scarlata; Marco Santonico; Chiara Vernile; Livio Cortese; Elena Frezzotti; Claudio Pedone; Arnaldo D'Amico
Journal:  Sleep Breath       Date:  2014-10-17       Impact factor: 2.816

6.  Residual sleepiness in veterans with post-traumatic stress disorder and obstructive sleep apnea.

Authors:  Ali A El-Solh; Hoang Bui; Yolanda Lawson; Parveen Attai
Journal:  Sleep Breath       Date:  2022-07-08       Impact factor: 2.816

Review 7.  Hypersomnia.

Authors:  Pradeep C Bollu; Sivaraman Manjamalai; Mahesh Thakkar; Pradeep Sahota
Journal:  Mo Med       Date:  2018 Jan-Feb

8.  Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.

Authors:  Russell Rosenberg; Michelle Baladi; Morgan Bron
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

9.  Prevalence of sleepiness and associations with quality of life in patients with sleep apnea in an online cohort.

Authors:  Lindsey J Wanberg; Rebecca E Rottapel; Michelle L Reid; Suzanne M Bertisch; Morgan Bron; Vishesh K Kapur; Shay Bujanover; Zinta Harrington; Jessie P Bakker; Sogol Javaheri; Mark Hanson; Kathleen Figetakis; Kathy Page; Sherry Hanes; Kathleen F Villa; Susan Redline
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

10.  Relationship between sleep efficacy endpoints and measures of functional status and health-related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness.

Authors:  Terri E Weaver; Susan D Mathias; Ross D Crosby; Morgan Bron; Shay Bujanover; Diane Menno; Kathleen F Villa; Christopher Drake
Journal:  J Sleep Res       Date:  2020-10-13       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.